Abstract
Post-streptococcal reactive arthritis is a frequently observed entity that has an uncertain relationship with acute rheumatic fever. Although different criteria have been suggested for delineating these two conditions, none have been validated. In the absence of a clear definition, it has been impossible for investigators to carry out meaningful studies. Some children who were initially labeled as having post-streptococcal reactive arthritis later suffered from carditis and definite rheumatic fever with subsequent streptococcal infections. Some physicians now recommend that all children with post-streptococcal reactive arthritis receive penicillin prophylaxis. However, the proper duration of treatment and appropriate guidelines for patient selection have not been determined. It will be impossible to answer these questions until collaborative efforts are made to accurately define this illness and then begin a careful analysis of its etiopathogenesis and natural history. In the interim, each physician must evaluate the potential risks and benefits of penicillin prophylaxis in view of the risk of rheumatic fever in the community.
Similar content being viewed by others
References and Recommended Reading
Fink CW: The role of the streptococcus in poststreptococcal reactive arthritis and in childhood polyarteritis nodosa. J Rheumatol 1991, 18:14–20.
Moon RY, Greene MG, Rehe GT, Katona IM: Poststreptococcal reactive arthritis in children: a potential predecessor of rheumatic heart disease. J Rheumatol 1995, 22:529–532. An interesting review of post-streptococcal reactive arthritis followed by heart disease.
DeCunto CL, Giannini EH, Fink CW, Brewer EJ, Person DA:Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J 1988, 7:683–686. Another interesting review of post-streptococcal reactive arthritis followed by heart disease.
Gibofsky A, Zabriskie JB: Rheumatic fever and poststreptococcal reactive arthritis. Curr Opin Rheumatol 1995, 7:299–305.
Ayoub EM, Majeed HA: Poststreptococcal reactive arthritis. Curr Opin Rheumatol 2000, 12:306–310.
Bont L, Brus F, Dijkman-Neerincx RHM, et al.: The clinical spectrum of post-streptococcal syndromes with arthritis in children. Clin Exp Rheumatol 1998, 16:750–752.
Jones TD: The diagnosis of rheumatic fever. JAMA 1944, 126:481–484.
Dajani A, Taubert K, Ferrieri P, et al.: Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever. Pediatrics 1995, 96:758–764. The most recent official statement of the American Heart Association that briefly addresses post-streptococcal reactive arthritis.
Maeno N, Yoshinaga M, Takei S, et al.: Anti-M protein antibody in post-streptococcal reactive arthritis. J Rheumatol 1999, 26:1417–1419.
Mori K, Kamikawaji N, Sasuzuki T: Persistent elevation of immunoglobulin G titer against the C region of recombinant group A streptococcal M protein in patients with rheumatic fever. Pediatr Res 1996, 39:336–342.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lehman, T.J.A., Edelheit, B.S. Clinical trials for post-streptococcal reactive arthritis. Curr Rheumatol Rep 3, 363–364 (2001). https://doi.org/10.1007/s11926-996-0004-8
Issue Date:
DOI: https://doi.org/10.1007/s11926-996-0004-8